By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Advion BioSciences today announced that it has signed a definitive agreement to sell its BioServices division to Quintiles Transnational for an undisclosed amount of cash.

Advion BioServices is a bioanalytical lab offering pharmacokinetic/pharmacodynamics testing and other services. The sale will allow Advion to focus on its core systems and consumables business.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.